The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes
Open accessAbstract
Metal-dependent histone deacetylases (HDACs) catalyze the hydrolysis of acetyl-L-lysine side chains in histone and non-histone proteins to yield L-lysine and acetate. This chemistry plays a critical role in the regulation of numerous biological processes. Aberrant HDAC activity is implicated in various diseases, and HDACs are validated targets for drug design. Two HDAC inhibitors are currently approved for cancer chemotherapy, and other inhibitors are in clinical trials. To date, X-ray crystal structures are available for four human HDACs (2, 4, 7, 8) and three HDAC-related deacetylases from bacteria (histone deacetylase-like protein, HDLP; histone deacetylase-like amidohydrolase, HDAH; acetylpolyamine amidohydrolase, APAH). Structural comparisons among these enzymes reveal a conserved constellation of active site residues, suggesting a common mechanism for the metal-dependent hydrolysis of acetylated substrates. Structural analyses of HDACs and HDAC-related deacetylases guide the design of tight-binding inhibitors, and future prospects for developing isozyme-specific inhibitors are quite promising.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Haberland, M., Montgomery, R. L., & Olson, E. N. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,526
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Gregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456
Lysine Acetylation: Codified Crosstalk with Other Posttranslational Modifications
Yang, X.-J., & Seto, E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.002 · Cited by 1,006
Histone Deacetylase Inhibitors in Cancer Therapy
Lane, A. A., & Chabner, B. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1291 · Cited by 874
(2002) · PubMed · Cited by 732
Histone deacetylase inhibitors: Potential in cancer therapy
Marks, P. A., & Xu, W. ‐. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22185 · Cited by 712
Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710 · cited 1×
“To date, this α/β fold has been observed in structures of the catalytic domains of HDAC2 [18••], HDAC4 [19], and HDAC7 [20], and full-length HDAC8 [21, 22].”
BackgroundStructural basis of the action of thermolysin and related zinc peptidases
Matthews, B. W. (1988) · Accounts of Chemical Research · doi:10.1021/ar00153a003 · Cited by 687
Vannini, A., Volpari, C., Filocamo, G., Casavola, E. C., Brunetti, M., Renzoni, D., Chakravarty, P., Paolini, C., De Francesco, R., Gallinari, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404603101 · Cited by 638
Christianson, D. W., & Lipscomb, W. N. (1989) · Accounts of Chemical Research · doi:10.1021/ar00158a003 · Cited by 606
Self-citationStructure of a unique binuclear manganese cluster in arginase
Kanyo, Z. F., Scolnick, L. R., Ash, D. E., & Christianson, D. W. (1996) · Nature · doi:10.1038/383554a0 · Cited by 441 · cited 1×
“Surprisingly, however, the α/β deacetylase fold seen in HDLP was first observed three years earlier in arginase, a binuclear manganese metalloenzyme [14].”
BackgroundSelf-citationTaori, K., Paul, V. J., & Luesch, H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja7110064 · Cited by 428
Bottomley, M. J., Lo Surdo, P., Di Giovine, P., Cirillo, A., Scarpelli, R., Ferrigno, F., Jones, P., Neddermann, P., De Francesco, R., Steinkühler, C., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803514200 · Cited by 312
Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides
Bressi, J. C., Jennings, A. J., Skene, R., Wu, Y., Melkus, R., Jong, R. D., O’Connell, S., Grimshaw, C. E., Navre, M., & Gangloff, A. R. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.091 · Cited by 261
Schuetz, A., Min, J., Allali-Hassani, A., Schapira, M., Shuen, M., Loppnau, P., Mazitschek, R., Kwiatkowski, N. P., Lewis, T. A., Maglathin, R. L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707362200 · Cited by 257
Vannini, A., Volpari, C., Gallinari, P., Jones, P., Mattu, M., Carfí, A., De Francesco, R., Steinkühler, C., & Di Marco, S. (2007) · The EMBO Reports · doi:10.1038/sj.embor.7401047 · Cited by 256
Holmes, M. A., & Matthews, B. W. (1981) · Biochemistry · doi:10.1021/bi00527a026 · Cited by 231
Total Synthesis and Molecular Target of Largazole, a Histone Deacetylase Inhibitor
Ying, Y., Taori, K., Kim, H., Hong, J., & Luesch, H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8013727 · Cited by 222
Isoform-specific histone deacetylase inhibitors: The next step?
Balasubramanian, S., Verner, E., & Buggy, J. J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.013 · Cited by 220
Dowling, D. P., Gantt, S. L., Gattis, S. G., Fierke, C. A., & Christianson, D. W. (2008) · Biochemistry · doi:10.1021/bi801610c · Cited by 200
Self-citationHistone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders
Pang, M., & Zhuang, S. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168385 · Cited by 173
Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders
Grayson, D. R., Kundakovic, M., & Sharma, R. P. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061333 · Cited by 171 · cited 1×
“The HDACs are being studied as drug targets for certain cancers [6–8], fibrotic diseases [9], cardiorenal disorders [10], neurodegeneration [11], and psychiatric disorders [12].”
BackgroundLeipe, D. D., & Landsman, D. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.18.3693 · Cited by 168
Arginase: Structure, Mechanism, and Physiological Role in Male and Female Sexual Arousal
Christianson, D. W. (2005) · Accounts of Chemical Research · doi:10.1021/ar040183k · Cited by 166
Self-citationBowers, A., West, N., Taunton, J., Schreiber, S. L., Bradner, J. E., & Williams, R. M. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8033763 · Cited by 165
Whitehead, L., Dobler, M. R., Radetich, B., Zhu, Y., Atadja, P. W., Claiborne, T., Grob, J. E., McRiner, A., Pancost, M. R., Patnaik, A., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.030 · Cited by 164
Crystal Structure of a Bacterial Class 2 Histone Deacetylase Homologue
Nielsen, T. K., Hildmann, C., Dickmanns, A., Schwienhorst, A., & Ficner, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.065 · Cited by 158
Cole, K. E., Dowling, D. P., Boone, M. A., Phillips, A. J., & Christianson, D. W. (2011) · Journal of the American Chemical Society · doi:10.1021/ja205972n · Cited by 153
Self-citationGantt, S. L., Gattis, S. G., & Fierke, C. A. (2006) · Biochemistry · doi:10.1021/bi060212u · Cited by 151
HDAC inhibitors and neurodegeneration: At the edge between protection and damage
Dietz, K. C., & Casaccia, P. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.011 · Cited by 138
Protein Acetylation in the Cardiorenal Axis: The Promise of Histone Deacetylase Inhibitors
Bush, E. W., & McKinsey, T. A. (2010) · Circulation Research · doi:10.1161/circresaha.109.209338 · Cited by 126
Bowers, A. A., West, N. H., Newkirk, T. L., Troutman-Youngman, A. E., Schreiber, S. L., Wiest, O., Bradner, J. E., & Williams, R. M. (2009) · Organic Letters · doi:10.1021/ol900078k · Cited by 113
EPR evidence for binuclear manganese(II) centers in rat liver arginase
Reczkowski, R. S., & Ash, D. E. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00053a064 · Cited by 112
Role of histone deacetylase inhibitors in the treatment of cancer (Review)
Mei, S., Ho, A. D., & Mahlknecht, U. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.6.1509 · Cited by 109
Macrocyclic Histone Deacetylase Inhibitors
Mwakwari, S. C., Patil, V., Guerrant, W., & Oyelere, A. K. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610792232079 · Cited by 96
Dowling, D., Gattis, S. G., Fierke, C. A., & Christianson, D. W. (2010) · Biochemistry · doi:10.1021/bi1005046 · Cited by 90
Self-citationActivation and Inhibition of Histone Deacetylase 8 by Monovalent Cations
Gantt, S. L., Joseph, C. G., & Fierke, C. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033399 · Cited by 87
Evolution of the arginase fold and functional diversity
Dowling, D., Costanzo, L. D., Gennadios, H. A., & Christianson, D. W. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7554-z · Cited by 80
Self-citationSAD phasing using iodide ions in a high-throughput structural genomics environment
Abendroth, J. A., Gardberg, A. S., Robinson, J. I., Christensen, J., Staker, B. L., Myler, P. J., Stewart, L. J., & Edwards, T. E. (2011) · Journal of Structural and Functional Genomics · doi:10.1007/s10969-011-9101-7 · Cited by 75
Das, C., & Kundu, T. K. (2005) · IUBMB Life · doi:10.1080/15216540500090629 · Cited by 73
Christianson, D. W., & Lipscomb, W. N. (1986) · Journal of the American Chemical Society · doi:10.1021/ja00276a048 · Cited by 73
Self-citationOn the evolution of arginases and related enzymes
Ouzounis, C., & Kyrpides, N. C. (1994) · Journal of Molecular Evolution · doi:10.1007/bf00178255 · Cited by 71
Riester, D., Wegener, D., Hildmann, C., & Schwienhorst, A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.155 · Cited by 68
Non-Peptide Macrocyclic Histone Deacetylase Inhibitors Derived from Tricyclic Ketolide Skeleton
Mwakwari, S. C., Guerrant, W., Patil, V., Khan, S. I., Tekwani, B. L., Gurard‐Levin, Z. A., Mrksich, M., & Oyelere, A. K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100507q · Cited by 68
Non-Peptide Macrocyclic Histone Deacetylase Inhibitors
Oyelere, A. K., Chen, P. C., Guerrant, W., Mwakwari, S. C., Hood, R., Zhang, Y., & Fan, Y. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801128g · Cited by 64
Botta, C. B., Cabri, W., Cini, E., Cesare, L. D., Fattorusso, C., Giannini, G., Persico, M., Petrella, A., Rondinelli, F., Rodriquez, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101373a · Cited by 57
The Activity of HDAC8 Depends on Local and Distal Sequences of Its Peptide Substrates
Gurard‐Levin, Z. A., & Mrksich, M. (2008) · Biochemistry · doi:10.1021/bi800053v · Cited by 55
Lombardi, P. M., Angell, H. D., Whittington, D. A., Flynn, E. F., Rajashankar, K. R., & Christianson, D. W. (2011) · Biochemistry · doi:10.1021/bi101859k · Cited by 53
Self-citationSakurada, K., Ohta, T., Fujishiro, K., Hasegawa, M., & Aisaka, K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.19.5781-5786.1996 · Cited by 46
Haider, S. M., Joseph, C. G., Neidle, S., Fierke, C. A., & Fuchter, M. J. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.128 · Cited by 40
Clinical development of histone deacetylase inhibitor romidepsin.
Guan, P. F., & Fang, H. (2010) · PubMed · Cited by 15
Cited by
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
Hai, Y., & Christianson, D. W. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2134 · Cited by 521
Self-citationA short guide to histone deacetylases including recent progress on class II enzymes
Park, S.-Y., & Kim, J.-S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0382-4 · Cited by 509
Overview of Histone Modification
Zhang, Y., Sun, Z., Jia, J., Du, T., Zhang, N., Tang, Y., Fang, Y., & Fang, D. (2021) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-8104-5_1 · Cited by 467
Structural insights into HDAC6 tubulin deacetylation and its selective inhibition
Miyake, Y., Keusch, J. J., Wang, L., Saito, M., Hess, D., Wang, X., Melancon, B. J., Helquist, P., Gut, H., & Matthias, P. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2140 · Cited by 315
Tatone, C., Di Emidio, G., Barbonetti, A., Carta, G., Luciano, A. M., Falone, S., & Amicarelli, F. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy003 · Cited by 294
Metadata
- Authors
- Lombardi, P. M., Cole, K. E., Dowling, D. P., & Christianson, D. W.
- Venue
- Current Opinion in Structural Biology
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 21
- Issue
- 6
- Pages
- 735-743
- ISSN
- 0959-440X (ISSN-L)
- OpenAlex
- W2009954700
- Cited by
- 277
- References
- 54
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.